T A Lister Selected Research

T A Lister Research Topics

Disease

8	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2004 - 01/2000
7	Neoplasms (Cancer) 04/2003 - 01/2000
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2005 - 02/2000
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2012 - 03/2000
4	Lymphoma (Lymphomas) 05/2006 - 07/2000
3	Hodgkin Disease (Hodgkin's Disease) 06/2013 - 06/2000
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2008 - 11/2000
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2004 - 01/2000
2	Breast Neoplasms (Breast Cancer) 06/2013 - 02/2000
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2004 - 01/2000
2	Disease Progression 08/2003 - 01/2000
2	Splenomegaly 04/2003 - 01/2000
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2003 - 01/2000
2	Lung Neoplasms (Lung Cancer) 03/2001 - 02/2000
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2000 - 01/2000
1	Fibrosis (Cirrhosis) 11/2008
1	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2003
1	Pathologic Complete Response 08/2003
1	Cytopenia 04/2003
1	Anemia 04/2003
1	Lymphadenopathy 04/2003
1	Hepatomegaly 04/2003
1	Thrombocytopenia (Thrombopenia) 04/2003
1	Infertility (Sterility) 07/2002
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2001
1	Adenocarcinoma 03/2001
1	Acute Promyelocytic Leukemia 08/2000
1	Leukemia 02/2000
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2000
1	Philadelphia Chromosome 01/2000
1	Infections 01/2000
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2000

Drug/Important Bio-Agent (IBA)

5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2008 - 05/2001
5	Vincristine (Oncovin)FDA LinkGeneric 11/2008 - 07/2000
5	Rituximab (Mabthera)FDA Link 11/2008 - 01/2000
4	Chlorambucil (Leukeran)FDA Link 04/2003 - 07/2000
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2008 - 08/2000
3	Prednisone (Sone)FDA LinkGeneric 11/2008 - 03/2001
3	fludarabineIBA 04/2003 - 01/2000
2	InterferonsIBA 04/2005 - 07/2001
2	IodineIBA 04/2004 - 10/2001
2	fludarabine phosphate (Fludara)FDA LinkGeneric 04/2004 - 01/2000
2	Prednisolone (Predate)FDA LinkGeneric 04/2003 - 07/2002
2	Procarbazine (Matulane)FDA Link 07/2002 - 03/2001
2	Bleomycin (Blenoxane)FDA LinkGeneric 07/2002 - 07/2000
2	DNA (Deoxyribonucleic Acid)IBA 11/2001 - 11/2000
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2000 - 07/2000
2	Monoclonal AntibodiesIBA 04/2000 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 01/2000 - 01/2000
1	CCAAT-Enhancer-Binding ProteinsIBA 07/2012
1	SeleniumIBA 05/2006
1	Selenium CompoundsIBA 05/2006
1	selenodiglutathioneIBA 05/2006
1	methylselenic acidIBA 05/2006
1	TabletsIBA 04/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2003
1	AlbuminsIBA 04/2003
1	Immunoglobulin M (IgM)IBA 04/2003
1	Hemoglobins (Hemoglobin)IBA 04/2003
1	Etoposide (VP 16)FDA LinkGeneric 07/2002
1	4-O-carboxymethylascochlorinIBA 07/2002
1	Vinblastine (Vinblastine Sulfate)FDA Link 07/2002
1	tositumomab I-131 (Bexxar)FDA Link 10/2001
1	carboranyl oligophosphate CB10IBA 07/2001
1	Mechlorethamine (Nitrogen Mustard)FDA Link 03/2001
1	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2000
1	Thioguanine (Tioguanine)FDA Link 08/2000
1	Methotrexate (Mexate)FDA LinkGeneric 07/2000
1	Lomustine (CCNU)FDA Link 07/2000
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2000
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2000
1	thiamine triphosphorate (TTP)IBA 01/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2000
1	AnthracyclinesIBA 01/2000
1	Alkylating AgentsIBA 01/2000
1	AcidsIBA 01/2000

Therapy/Procedure

13	Therapeutics 04/2003 - 01/2000
7	Drug Therapy (Chemotherapy) 04/2005 - 02/2000
6	Aftercare (After-Treatment) 11/2008 - 01/2000
3	Radiotherapy 06/2013 - 02/2000
2	Combination Drug Therapy (Combination Chemotherapy) 11/2008 - 04/2003
2	Remission Induction 08/2000 - 01/2000
1	Transplantation 08/2003
1	Hematopoietic Stem Cell Transplantation 08/2003
1	Homologous Transplantation 08/2003